FGF19 and Disorder of lipid metabolism: Generally, the serum metabolomic profile through mice intraperitoneal-injected LPS with or without FGF19 pretreatment, IPA analysis, and our further validation tests revealed FGF19 improved LPS-induced lipid metabolic disorder and organ injury, which was associated with LA/GLA-generation of ROS pathway.